320 related articles for article (PubMed ID: 28858107)
1. Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasms.
Xu MM; Yin S; Siddiqui AA; Salem RR; Schrope B; Sethi A; Poneros JM; Gress FG; Genkinger JM; Do C; Brooks CA; Chabot JA; Kluger MD; Kowalski T; Loren DE; Aslanian H; Farrell JJ; Gonda TA
Medicine (Baltimore); 2017 Sep; 96(35):e7900. PubMed ID: 28858107
[TBL] [Abstract][Full Text] [Related]
2. Comparing American Gastroenterological Association Pancreatic Cyst Management Guidelines with Fukuoka Consensus Guidelines as Predictors of Advanced Neoplasia in Patients with Suspected Pancreatic Cystic Neoplasms.
Ma GK; Goldberg DS; Thiruvengadam N; Chandrasekhara V; Kochman ML; Ginsberg GG; Vollmer CM; Ahmad NA
J Am Coll Surg; 2016 Nov; 223(5):729-737.e1. PubMed ID: 27497827
[TBL] [Abstract][Full Text] [Related]
3. Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
Sighinolfi M; Quan SY; Lee Y; Ibaseta A; Pham K; Dua MM; Poultsides GA; Visser BC; Norton JA; Park WG
Dig Dis Sci; 2017 Mar; 62(3):626-632. PubMed ID: 28116593
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
5. Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.
Kaimakliotis P; Riff B; Pourmand K; Chandrasekhara V; Furth EE; Siegelman ES; Drebin J; Vollmer CM; Kochman ML; Ginsberg GG; Ahmad NA
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1808-15. PubMed ID: 25818077
[TBL] [Abstract][Full Text] [Related]
6. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
[TBL] [Abstract][Full Text] [Related]
7. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
8. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas.
Sawhney MS; Al-Bashir S; Cury MS; Brown A; Chuttani R; Pleskow DK; Callery MP; Vollmer CM
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1373-6. PubMed ID: 19577006
[TBL] [Abstract][Full Text] [Related]
9. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome.
Lekkerkerker SJ; Besselink MG; Busch OR; Verheij J; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
Gastrointest Endosc; 2017 May; 85(5):1025-1031. PubMed ID: 27693645
[TBL] [Abstract][Full Text] [Related]
10. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
Dbouk M; Brewer Gutierrez OI; Lennon AM; Chuidian M; Shin EJ; Kamel IR; Fishman EK; He J; Burkhart RA; Wolfgang CL; Hruban RH; Goggins MG; Canto MI
Pancreatology; 2021 Apr; 21(3):613-621. PubMed ID: 33593706
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cyst size and tumor markers in the management of pancreatic cysts: support for the original Sendai criteria.
Hoffman RL; Gates JL; Kochman ML; Ginsberg GG; Ahmad NA; Chandrasekhara V; Furth EE; Vollmer CM; Drebin JA
J Am Coll Surg; 2015 Jun; 220(6):1087-95. PubMed ID: 25868415
[TBL] [Abstract][Full Text] [Related]
12. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
Smith AL; Abdul-Karim FW; Goyal A
Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
[TBL] [Abstract][Full Text] [Related]
13. Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional Study.
Wilson GC; Maithel SK; Bentrem D; Abbott DE; Weber S; Cho C; Martin RC; Scoggins CR; Kim HJ; Merchant NB; Kooby DA; Edwards MJ; Ahmad SA
J Am Coll Surg; 2017 Apr; 224(4):461-469. PubMed ID: 28088598
[TBL] [Abstract][Full Text] [Related]
14. Clinical criteria for integrated molecular pathology in intraductal papillary mucinous neoplasm: less is more.
Simpson RE; Cockerill NJ; Yip-Schneider MT; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Al-Haddad MA; Schmidt CM
HPB (Oxford); 2019 May; 21(5):574-581. PubMed ID: 30293868
[TBL] [Abstract][Full Text] [Related]
15. Importance of each high-risk stigmata and worrisome features as a predictor of high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Pancreatology; 2020 Jul; 20(5):895-901. PubMed ID: 32624417
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
Srinivasan N; Koh YX; Goh BKP
Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
[TBL] [Abstract][Full Text] [Related]
17. Uncinate Duct Dilatation Predicts Additional Risk for High-Grade Dysplasia or Invasive Carcinoma Among Fukuoka-Positive Intraductal Papillary Mucinous Neoplasms.
Yang AZ; Kongboonvijit S; Fernandez-Del Castillo CF; Fong ZV; Zelga PJ; Ferrone CR; Lillemoe KD; Kambadakone A; Qadan M
Ann Surg; 2023 Jun; 277(6):988-994. PubMed ID: 36804283
[TBL] [Abstract][Full Text] [Related]
18. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the accuracy of three international guidelines in identifying the risk of malignancy in pancreatic cysts: a retrospective analysis of a surgical treated population.
Vanden Bulcke A; Jaekers J; Topal H; Vanbeckevoort D; Vandecaveye V; Roskams T; Weynand BA; Dekervel J; Van Cutsem E; van Malenstein H; Verslype C; Laleman W; van der Merwe S
Acta Gastroenterol Belg; 2021; 84(3):443-450. PubMed ID: 34599569
[TBL] [Abstract][Full Text] [Related]
20. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts.
Heidarian A; Das KK; Mino-Kenudson M; Fernandez-Del Castillo C; Pitman MB
J Am Soc Cytopathol; 2021; 10(3):249-254. PubMed ID: 33541830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]